Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Registry-based Study to Evaluate Safety and Performance of EyenableTM Intraocular Lens Implantation After Cataract Removal

NCT06223113 is registered in ClinicalTrials.gov with Xi'an Eyedeal Medical Technology Co., Ltd as lead sponsor.

NCT NCT06223113
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06223113 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Registry-based Study to Evaluate Safety and Performance of EyenableTM Intraocular Lens Implantation After Cataract Removal
Lead sponsor
Xi'an Eyedeal Medical Technology Co., Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
February 29, 2024
Completion date
February 28, 2025
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cataract